Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
07/2010
07/27/2010CA2470105C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents
07/27/2010CA2445625C Pyrazino'1',2':1,6!pyrido'3,4-b!indole1,4-dione derivatives
07/27/2010CA2436659C Cannabinoid receptor ligands
07/27/2010CA2427569C Selective glucocorticoid receptor agonists
07/27/2010CA2404000C A functional assay of high-density lipoprotein
07/27/2010CA2384717C Topical treatment for prevention of ocular infections
07/27/2010CA2224080C Relaxin-like factor and methods and uses thereof
07/22/2010WO2010083241A2 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
07/22/2010WO2010083240A2 Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds
07/22/2010WO2010083239A2 Therapeutic modulation of vaginal epithelium boundary lubrication
07/22/2010WO2010083237A2 Composition and methods to manage the inflammatory basis of chronic disease conditions and maintain an optimal immune response in elderly
07/22/2010WO2010083220A1 Benzoxazole inhibitors of poly(adp-ribose)polymerase
07/22/2010WO2010083218A1 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
07/22/2010WO2010083207A2 Protein kinase c inhibitors and uses thereof
07/22/2010WO2010081859A1 6-phenyl-lh-imidazo [4, 5-c] pyridine-4-carbonitrile derivatives as cathepsin s and/or cathepsin k inhibitors
07/22/2010WO2010081666A1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
07/22/2010WO2010062372A3 Methods for modulating nf-kb using gibberellins
07/22/2010WO2010048731A8 Aminoacyl trna-synthetase inhibitors as broad-spectrum immunosuppressive agents
07/22/2010WO2010040055A3 Oral pharmaceutical formulations for antidiabetic compounds
07/22/2010WO2010037059A3 Heteroaryl antagonists of prostaglandin d2 receptors
07/22/2010WO2010036065A3 Pharmaceutical composition for preventing and treating inflammatory diseases, containing an ethyl acetate fraction of dried extract of trachelospermi caulis as an active ingredient, and method for producing the fraction
07/22/2010WO2010028338A3 Novel compounds as cannabinoid receptor ligands
07/22/2010WO2010022196A3 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase
07/22/2010WO2010015586A3 2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds
07/22/2010WO2010012438A3 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor
07/22/2010US20100184856 Novel Compounds and Uses Thereof for Treating Inflammation and Modulating Immune Responses
07/22/2010US20100184825 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue
07/22/2010US20100184824 RNA Interference Mediated Inhibition of Interleukin and Interleukin Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA)
07/22/2010US20100184802 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof
07/22/2010US20100184791 Compounds and compositions as c-kit and pdgfr kinase inhibitors
07/22/2010US20100184789 Inhibitors of protein kinases
07/22/2010US20100184786 Polar Quinazolines
07/22/2010US20100184781 Fxa inhibitors with cyclic amidines as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
07/22/2010US20100184780 Inhibitors of protein kinases
07/22/2010US20100184778 Novel heterocycle compounds and uses thereof
07/22/2010US20100184770 Compounds
07/22/2010US20100184768 Isoprenyl Compounds and Methods Thereof
07/22/2010US20100184767 Substituted oxazolidinones and use thereof
07/22/2010US20100184763 Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
07/22/2010US20100184762 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof
07/22/2010US20100184760 Benzoxazole kinase inhibitors and methods of use
07/22/2010US20100184759 Pyrano-pyrazole-amines
07/22/2010US20100184755 Protein kinase c inhibitors and uses thereof
07/22/2010US20100184747 Indoline derivatives and their use in treating disease-states such as cancer
07/22/2010US20100184740 Substituted oxazolidinones and their use
07/22/2010US20100184728 Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
07/22/2010US20100184717 Treatment of Statin Side Effects Using Uridine Derivatives
07/22/2010US20100184708 Use of gly-pro-glu-oh (gpe) as a therapeutic agent
07/22/2010US20100184705 Therapeutic Peptides and Vaccines
07/22/2010US20100184704 Use of the peptide gly-arg-gly-asp-asn-pro as a therapeutic agent
07/22/2010US20100184698 Use of a deslorelin and mastoparan as a therapeutic agent
07/22/2010US20100184685 Systems and methods for treating post- operative, acute, and chronic pain using an intra-muscular catheter administrated combination of a local anesthetic and a neurotoxin protein
07/22/2010US20100184675 Use of glucagon (1-29) alone or in combination with neuropeptide w30 as a therapeutic agent
07/22/2010US20100184674 Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agent
07/22/2010US20100184646 Melanocortin receptor ligands modified with hydantoin
07/22/2010US20100183734 Influence of genotype on susceptibility to treatment with fish oil
07/22/2010US20100183714 Gastroresistant pharmaceutical dosage form comprising n-(2-(2- phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic acid (lk-423)
07/22/2010US20100183713 Gastrointestinal-specific multiple drug release system
07/22/2010US20100183636 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
07/22/2010US20100183632 Antibody Therapy For Modulating Function Of Intestinal Receptors
07/22/2010US20100183619 Neutralizing Antibodies and Methods of Use Thereof
07/22/2010US20100183616 Antibodies against interleukin-1 beta
07/22/2010US20100183609 Taci-immunoglobulin fusion proteins
07/22/2010US20100183602 Induction of Tolerogenic Phenotype in Mature Dendritic Cells
07/22/2010US20100183567 Novel Mammalian Multipotent Stem Cells and Compositions, Methods of Preparation and Methods of Administration Thereof
07/22/2010US20100183560 Angiogenesis-modulating compositions and uses
07/22/2010CA2749585A1 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
07/22/2010CA2749348A1 6-phenyl-ih-imidazo [4, 5-c] pyridine-4-carbonitrile derivatives as cathepsin s and/or cathepsin k inhibitors
07/22/2010CA2749248A1 Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds
07/22/2010CA2749195A1 Protein kinase c inhibitors and uses thereof
07/22/2010CA2749157A1 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
07/21/2010EP2208499A1 Nucleic acid capable of regulating the proliferation of cell
07/21/2010EP2207819A1 Anti-microbial polymers and their compositions
07/21/2010EP2207776A1 Drug active in neuropathic pain
07/21/2010EP2207772A1 Thiophene-2-carboxamide derivatives as modulators of ccr9 receptor
07/21/2010EP2207541A1 Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid n-phenylamides in the treatment of pain
07/21/2010EP1487444B9 Use of pyridyl amides as inhibitors of angiogenesis
07/21/2010EP1411900B1 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
07/21/2010EP1265866B1 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
07/21/2010EP1079825B1 Compounds that inhibit the binding of integrins to their receptors
07/21/2010EP0702566B1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
07/21/2010CN1886389B Quinoxaline compounds
07/21/2010CN1826310B Novel aminobenzophenone compounds
07/21/2010CN1823747B Paeonol film coated drip pill and its preparation method
07/21/2010CN101784545A Compounds useful as raf kinase inhibitors
07/21/2010CN101784535A Novel dicarboxylic acid derivatives as S1P1 receptor agonists
07/21/2010CN101784273A (2S,3R)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
07/21/2010CN101784262A Immediate release and sustained release ibuprofen dosing regiment
07/21/2010CN101781353A 20(S)-ginsenoside Rh2 derivatives for regulating and controlling ER Alpha/ER Beta-TNF Alpha channel as well as preparation and anti-tumor application thereof
07/21/2010CN101781352A 20-O-glycosyl and protopanoxadiol compound and preparation method thereof
07/21/2010CN101781347A Polymorphic substances of decitabine and medical compositions
07/21/2010CN101780260A Traditional Chinese medicine decoction for treating gynecologic chronic pelvic pain
07/21/2010CN101780257A Traditional Chinese medicine for treating rheumatoid arthritis
07/21/2010CN101780243A Combined medicament for treating rheumatism and preparation method thereof
07/21/2010CN101780232A Coix seed oil proliposome and preparation method thereof
07/21/2010CN101780226A Plaster for treating bone injury
07/21/2010CN101780219A Medicinal preparation for treating toothache by using fumigation of traditional Chinese medicine and making method thereof
07/21/2010CN101780207A Traditional Chinese medicine for treating nervous headache
07/21/2010CN101780185A Health wine
07/21/2010CN101780181A Nitric oxide free radical health care product
1 ... 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 ... 1272